The EDC is live today — see what ships now
All studies
NCT07836231From ClinicalTrials.govRecruiting

Treating Intrabony Defect With MINST VS MINST Extended PRF

Clinical Effectiveness of Minimally Invasive Non-surgical Technique With or Without Extended Platelets Rich Fibrin in Intrabony Defects: a Randomized Controlled Clinical Trial

  • Periodontal Intrabony Defects

At a glance

Phase
Phase not stated
Study type
Interventional
Sponsor
Cairo University
Enrolment target
48
Started
26 May 2026
Main results due
1 July 2027
Study sites
1
Registry updated
23 September 2026

Can you take part?

  • Aged 18 years and over.
  • Open to any sex.
  • You need the condition being studied — healthy volunteers are not accepted.

These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.

Read the full eligibility criteria
Inclusion Criteria:

Adults aged above 21 years. Clinical diagnosis of Stage III periodontitis. Presence of at least two isolated interproximal intrabony defects located in different quadrants.

Intrabony defect associated with a single-rooted tooth or mandibular molar without furcation involvement.

Probing depth (PD) ≥ 6 mm. Radiographic intrabony defect depth between 3 and 7 mm. Absence of periapical pathology at the study site. Absence of acute periodontal infection. Absence of subgingival restorations that could interfere with clinical measurements.

Absence of Grade II or Grade III tooth mobility. Ability and willingness to provide written informed consent.

Exclusion Criteria:

Pregnancy or lactation. Non-surgical periodontal therapy within the previous 6 months. Surgical periodontal therapy within the previous 12 months. History of radiotherapy to the head and neck region. Current smoking.

Eligibility note: Former smokers and never-smokers are eligible.

What this study is about

In the sponsor’s own words, from the registry.

This study evaluates a minimally invasive non-surgical technique (MINST) for treating periodontal intrabony defects, with or without the addition of Extended Platelet-Rich Fibrin (e-PRF). The goal is to determine which approach provides better bone regeneration and gum healing.

Study Procedures

Control Group:

Local anesthesia by infiltration at the treatment site

Instrumentation of the root surface up to the bottom of the periodontal pocket

Efforts are made to minimize trauma to soft tissues and interdental papilla using subpapillary access

Cleaning is performed using piezo-electric devices with delicate tips, avoiding aggressive root smoothing or gingival curettage

3-4× magnification loupes are used to improve precision

Intervention Group:

All the above procedures

Followed by injection of e-PRF, a preparation derived from the patient's own blood

Blood is collected in 4 mL tubes and centrifuged at 700 g for 8 minutes

The platelet-poor plasma is heated to create an albumin gel

The remaining buffy coat (rich in platelets and growth factors) is mixed with the cooled albumin gel to form Alb-PRF, which is applied to the defect

Study sites(1)

  • Faculty of Dentistry, Cairo University

    Giza, Giza Governorate, Egypt

    Recruiting

Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.

Source: ClinicalTrials.gov record NCT07836231. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.

Not the right study?

Answer three questions and see the studies recruiting near you, in plain language.

Find a study for me
Treating Intrabony Defect With MINST VS MINST Extended PRF | Trialion